SCHEMBL8022367

SCHEMBL8022367

O=C(c1cccc(F)c1)c1ccccc1[AsH2]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.53
CES1 P23141 2/20 0.53
PARP1 P09874 1/20 0.50
NPC1 O15118 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
TSHR P16473 1/20 0.49
ALOX12 P18054 1/20 0.49
HTT P42858 1/20 0.49
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
RAB9A P51151 3/20 0.44
PKM P14618 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
BDKRB1 P46663 1/20 0.44
KCNK3 O14649 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1513045 0.82 CES2 (0.57) CES2CES1PARP1NPC1MEN1
SCHEMBL10997315 0.81 AKR1C3 (0.66) CES2CES1PARP1NPC1MEN1
SCHEMBL4781877 0.80 LTA4H (0.46) CES2CES1NPC1MEN1KMT2A
SCHEMBL29963651 0.79 MAPT (0.65) CES2CES1PARP1NPC1MEN1
SCHEMBL9397130 0.79 POLB (0.54) CES2CES1PARP1NPC1MEN1
SCHEMBL4416792 0.79 MAPT (0.65) CES2CES1PARP1NPC1MEN1
SCHEMBL5531918 0.79 AKR1C3 (0.61) MEN1KMT2ALMNAKDM4EMAPT
SCHEMBL1258944 0.79 CES2 (0.74) CES2CES1PARP1NPC1MEN1
Hydrochloric Acid SCHEMBL27671270 0.78 CES2 (0.52) CES2CES1PARP1NPC1MEN1
SCHEMBL29623677 0.77 ATM (0.71) CES2CES1PARP1NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968198-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE Elan Pharmaceuticals, Inc. (US) 2000-01-05 EP disclosed
WO-1998038177-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING β-AMYLOID PEPTIDE ELAN PHARMACEUTICALS, INC. (US) 1998-09-03 WO disclosed